Glassman Wealth Services Bluebird Bio, Inc. Transaction History

Glassman Wealth Services

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$2.94 - $5.23 $679 - $1,208	-231 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$4.07 - $10.6 $773 - $2,014	190 Added 463.41%	231 $1,000
Q4 2021 Feb 14, 2022	BUY	$8.96 - $16.31 $143 - $260	16 Added 64.0%	41 $0
Q3 2021 Nov 10, 2021	BUY	$11.24 - $21.0 $281 - $525	25 New	25 $0
Q3 2020 Nov 09, 2020	SELL	$34.44 - $43.75 $792 - $1,006	-23 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$27.12 - $45.97 $623 - $1,057	23 New	23 $1,000
Q4 2019 Feb 07, 2020	SELL	$46.96 - $61.67 $563 - $740	-12 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$59.47 - $93.1 $237 - $372	4 Added 50.0%	12 $1,000
Q2 2019 Aug 08, 2019	BUY	$75.84 - $105.21 $606 - $841	8 New	8 $1,000
Q3 2018 Nov 13, 2018	SELL	$88.86 - $117.49 $266 - $352	-3 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$99.64 - $127.59 $298 - $382	3 New	3 $0

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $29.3M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.